Osteopore Ltd has released a press release.
OSX receives A$10m commitment for commercialisation in China
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Osteopore
- Osteopore strengthens Board & Management by key appointments
- Strategic Partnership for Clinical R&D in China worth $4M
- Largest South African Medical Insurer provides cover for OSX
- Activities Update Qtr Ending March 2023 and Appendix 4C
- OSX Successfully transitions to EU Medical Device Regulation
Later from Osteopore
- Activities Update Qtr Ending June 2023 and Appendix 4C
- MOU with Temasek-linked Innoventures - Orthopaedics in China
- Activities Update Qtr Ending September 2023 and Appendix 4C
- Osteopore signs Bridging Loan agreement
- Notice of General Meeting
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore